ArticleOncoTargets and therapy2018

Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro.

Yuhang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.